XML 57 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Concentration of Business Risk (Tables)
 9 Months Ended
Sep. 30, 2012
Concentration of Business Risk [Abstract]  
Revenue by geographic area

Revenue by geographic area was as follows (in thousands):

 

                                 
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2012     2011     2012     2011  

North America

   $ 3,400     $ 4,785     $ 13,514     $ 15,525  

Europe

     5,585       9,488       22,579       22,100  

South America

     978       3,860       6,097       8,542  

Asia

     299       283       998       779  
   

 

 

    

 

 

    

 

 

    

 

 

  
    $ 10,262     $ 18,416     $ 43,188     $ 46,946  
   

 

 

    

 

 

    

 

 

    

 

 

  
Product and manufacturing revenues by individual product line

The following table sets forth product and contract manufacturing revenues by individual product line (in thousands):

 

                                 
    Three Months Ended September 30,  
    2012     % of
Product
Revenue		     2011     % of
Product
Revenue		  

Product revenues:

                                

Animal health and nutrition

   $ 5,849       61 %    $ 8,624       58 % 

Grain processing

     2,054       21 %      3,942       27 % 

Oilseed processing (1)

     0       0 %      1,929       13 % 

All other products

     101       1 %      247       2 % 
   

 

 

    

 

 

    

 

 

    

 

 

  

Total product revenue

   $ 8,004       83 %    $ 14,742       100 % 

Contract manufacturing (1)

     1,561       17 %      0       0 % 
   

 

 

    

 

 

    

 

 

    

 

 

  

Total product and contract manufacturing revenue

   $ 9,565       100 %    $ 14,742       100 % 
   

 

 

    

 

 

    

 

 

    

 

 

  
                                 
    Nine Months Ended September 30,  
    2012     % of
Product
Revenue		     2011     % of
Product
Revenue		  

Product revenues:

                                

Animal health and nutrition

   $ 22,521       63 %    $ 24,734       59 % 

Grain processing

     7,895       22 %      12,371       29 % 

Oilseed processing (1)

     579       2 %      4,541       11 % 

All other products

     972       2 %      606       1 % 
   

 

 

    

 

 

    

 

 

    

 

 

  

Total product revenue

   $ 31,967       89 %    $ 42,252       100 % 

Contract manufacturing (1)

     4,047       11 %      0       0 % 
   

 

 

    

 

 

    

 

 

    

 

 

  

Total product and contract manufacturing revenue

   $ 36,014       100 %    $ 42,252       100 % 
   

 

 

    

 

 

    

 

 

    

 

 

  

 

(1) As the Company will continue to provide manufacturing services for the products sold and licensed to DSM, all revenue through the minimum term specified in the contract after the agreement date (March 23, 2012) is classified as contract manufacturing revenue on the Company’s condensed consolidated statements of comprehensive income (loss). All historical amounts related to Purifine and Veretase will continue to be shown as oilseed processing and grain processing product revenue.